Effective inhibition of cell growth and invasion of melanoma by combined suppression of BRAF (V599E) and Skp2 with lentiviral RNAi
Open Access
- 28 July 2005
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 118 (2), 472-476
- https://doi.org/10.1002/ijc.21286
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Gene therapy for human small-cell lung carcinoma by inactivation of Skp-2 with virally mediated RNA interferenceGene Therapy, 2004
- Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interferenceOncogene, 2004
- MAP Kinase-dependent Degradation of p27Kip1 by Calpains in Choroidal Melanoma CellsJournal of Biological Chemistry, 2003
- A Novel Target Gene, SKP2, within the 5p13 Amplicon That Is Frequently Detected in Small Cell Lung CancersThe American Journal of Pathology, 2002
- Mutations of the BRAF gene in human cancerNature, 2002
- Skp2 is oncogenic and overexpressed in human cancersProceedings of the National Academy of Sciences of the United States of America, 2001
- Role of the F-box protein Skp2 in lymphomagenesisProceedings of the National Academy of Sciences of the United States of America, 2001
- p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cellsNature, 1999
- The murine gene p27Kip1 is haplo-insufficient for tumour suppressionNature, 1998
- p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21Cell, 1994